{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T15:53:12Z","timestamp":1774885992435,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.ajo.2005.01.030","type":"journal-article","created":{"date-parts":[[2005,5,7]],"date-time":"2005-05-07T20:47:38Z","timestamp":1115498858000},"page":"1086-1089","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Celecoxib, a Selective Inhibitor of Cyclooxygenase 2 for Therapy of Diffuse Anterior Scleritis"],"prefix":"10.1016","volume":"139","author":[{"given":"Andrea M.","family":"Bauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Fiehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias D.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2005.01.030_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.01.030_bib2","first-page":"205","article-title":"Skleritis und Episkleritis","volume":"93","author":"Althaus","year":"1996","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.ajo.2005.01.030_bib3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0161-6420(91)32269-3","article-title":"Progression of scleral disease","volume":"98","author":"Tuft","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.01.030_bib4","first-page":"90","article-title":"The sclera in systemic disorders","author":"Watson","year":"1976"},{"key":"10.1016\/j.ajo.2005.01.030_bib5","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0161-6420(84)34160-4","article-title":"Mortality rate in rheumatoid arthritis patients developing necrotizing scleritis or peripheral ulcerative keratitis. Effects of systemic immunosuppression","volume":"91","author":"Foster","year":"1984","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.01.030_bib6","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1016\/S0161-6420(93)31473-9","article-title":"An analysis of therapeutic decision for scleritis","volume":"100","author":"Sainz de la Maza","year":"1993","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.01.030_bib7","doi-asserted-by":"crossref","first-page":"12866","DOI":"10.1016\/S0021-9258(18)98774-0","article-title":"TIS10, a phorbol ester tumor promotor-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandine synthase\/cyclooxygenase homologue","volume":"266","author":"Kujubu","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2005.01.030_bib8","doi-asserted-by":"crossref","first-page":"23261","DOI":"10.1016\/S0021-9258(18)54491-4","article-title":"A serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein","volume":"266","author":"O\u2019Banion","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajo.2005.01.030_bib9","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1096\/fasebj.12.12.1063","article-title":"Cyclooxygenase in biology and disease","volume":"12","author":"Dubois","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.ajo.2005.01.030_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archinte.160.7.913","article-title":"Unresolved issues in the role of cyclooxygenase-2 in normal physiologic processes and diseases","volume":"160","author":"Lipsky","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ajo.2005.01.030_bib11","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0161-6420(91)32280-2","article-title":"Immunopathology of scleritis","volume":"98","author":"Fong","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.01.030_bib12","first-page":"2718","article-title":"Autoimmune ocular disease in MRL\/Mp-Ipr\/Ipr mice is suppressed by anti-CD4 antibody","volume":"32","author":"Jabs","year":"1991","journal-title":"Invest Ophth Vis Sci"},{"key":"10.1016\/j.ajo.2005.01.030_bib13","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","article-title":"Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs","volume":"231","author":"Vane","year":"1971","journal-title":"Nature New Biol"},{"key":"10.1016\/j.ajo.2005.01.030_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00004397-199103130-00010","article-title":"Systemic associations of scleritis","volume":"31","author":"Hakin","year":"1991","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/j.ajo.2005.01.030_bib15","first-page":"217","article-title":"Use of topical steroid therapy in the management of non-necrotizing anterior scleritis","volume":"34","author":"McMullen","year":"1999","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.ajo.2005.01.030_bib16","first-page":"469","article-title":"Episcleritis and scleritis","volume":"130","author":"Jabs","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2005.01.030_bib17","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2005.01.030_bib18","first-page":"31","article-title":"Gastrointestinal safety and tolerability of nonselective nonsteroidal anti-inflammatory agents and cyclooxygenase-2-selective inhibitors","volume":"69","author":"Peura","year":"2000","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.ajo.2005.01.030_bib19","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of refecoxib and naproxen in patients with rheumatoid arthritis","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2005.01.030_bib20","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1056\/NEJMoa021907","article-title":"Celecoxib versus diclofenac and omeprazol in reducing the risk of recurrent ulcer bleeding in patients with arthritis","volume":"347","author":"Chan","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2005.01.030_bib21","first-page":"2553","article-title":"Urticaria and angioedema from cyclooxygenase-2 inhibitors","volume":"28","author":"Kelkar","year":"2001","journal-title":"J Rheumatol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939405000991?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939405000991?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:50:31Z","timestamp":1757595031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939405000991"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":21,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S0002939405000991"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2005.01.030","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Celecoxib, a Selective Inhibitor of Cyclooxygenase 2 for Therapy of Diffuse Anterior Scleritis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2005.01.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}